The aim of this article was to review some of the new and commonly used medicinal plants in the treatment of kidney stones, emphasizing medicinal uses, pharmacological activity, and research study of medicinal plants. Renal stones are a common problem worldwide with substantial morbidities and economic costs. The high economic burden associated with kidney stones is linked mainly with healthcare costs. In vitro and in vivo studies on alternative treatment of kidney stones have been searched by using words such as phytotherapy of kidney stones, medicinal plants used in kidney stones, and lithotriptic activity of plants. Articles reviewed showed that medicinal plants have lithotriptic potential. Medicinal plants may be useful in treatment of kidney stones. This study was aimed to explore and elaborate the efficacy and availability of alternative treatment for kidney stones and to provide safe, cost effective, and efficacious management options as well as reduce the burden of disease. Cost effectiveness may enable improvements in treatment efficiency that can benefit patients and the healthcare system. Further randomized clinical trials should be conducted to evaluate the safety and efficacy of medicinal plants.
Introduction
Urolithiasis is a common disorder and affects a considerable number of people worldwide. Globally, 12% of population suffers from kidney stone at a stage of life. During the past decades, incidence of kidney stones increased both in developing as well as developed countries mainly due to sedentary life style, eating habits, and global warming issues. According to a report, US population suffers from kidney stones 1 out of every 11 persons and in Asian countries about 1%-19.1% of the population suffers from urolithiasis such as in India 12% of total population suffers from urolithiasis and half of them have consequent failure of kidney mainly due to high cost of treatment. In China and United Arab Emirates, prevalence of kidney stones is 6.4% and 6.8 %, respectively. A significant economic burden is associated with kidney stones, with annual estimate exceeding US$5 billion in the United States. A theme that emerges from recent research is that the complexity of minerals and electrolyte imbalance involving other body systems can lead to urinary stone formation. Medicinal ligulata and Asparagus racemosus which are native to Pakistan and found worldwide. All medicinal plants are documented and some of them experimentally documented, but more or less traditionally can be viewed as the alternative source as therapeutics for different forms of kidney stones (calcium oxalate, uric acid, struvite and cysteine). The toxicity is minimum, and when there are side effects of conventional medicine herbal medicine can be a good alternative. There is evidence in treating kidney stones with herbal medicaments. The plant species listed have potential active compounds and may aid researchers in their study of natural products, which may be useful to treat kidney stones (calcium oxalate, uric acid, struvite and cysteine). In present study, we have documented medicinal plant usage in patients with urolithiasis. 
Oxalate stones
These stones are formed due to calcium oxalate and are popularly known as mulberry stones. It is covered with sharp projections, which may bleed early. These are usually single. Due to its irregularity, it produces symptoms early. These stones are usually very hard. In cross-section, it is seen as concentrically placed layers. The crystals can be seen in urine and identified by their envelope like shape.
Phosphate stones
These may occur as calcium phosphate, ammonium phosphate or triple phosphate (calcium, ammonium, and magnesium). These stones are smooth and dirty white in color. The stone enlarges in alkaline urine. It only gives symptoms when stone is large in size.
Uric acid
These are hard, smooth, and radiolucent. They are multiple and faceted, and yellow to reddish brown in color. These may be soft and flexible.
Cysteine stones
These may appear in the patient with cystinuria which may occur in the patient with reduced reabsorption of cysteine from the kidney. These are soft stones. On exposure to air, they change their color into green. This greenish color appears due to the presence of sulfur in them. These cysteine crystals are hexagonal, translucent, and appear in acidic urine.
Signs and symptoms
Some patients with small-sized stones do not produce any symptoms. Pain is the leading symptom in 75% of cases; pain is fixing, and located in renal angle. In case of ureteric colic, when stones radiate to ureter from the right or left lumbar region and then to the groin, there is also vomiting and sweating due to severe pain. On abdominal examination, there is tenderness in the abdomen muscles and if hydronephrosis has been produced, then the kidney becomes palpable. There is pyuria and hematuria.
Discussion

Medicinal plants with antilithiatic properties
Cynodon dactylon (Gramineae). The whole plant is used. 5 reported the efficacy of this plant in kidney stone.
Aerva lanata (Amaranthaceae). The whole plant and leaves are used. Common name is Gorakha ganja. Its chemical constituents are tannic acid, benzoic acid, lupeol, persinol, quercetin, ervoside and aervine. It is used in diabetes mellitus, urinary tract infections, kidney stones, and cancer. Its pharmacological activities are hypoglycemic, diuretic, hepatoprotective and nephroprotective. Soundararajan et al. 6 reported the efficacy of this plant on calcium oxalate urolithiasis in rats.
Crataeva nurvala (Capparaceae). Parts used are roots. Common name is Veruna. Its chemical constituents are triperpenoids, flavonoids, glucocapparine, betulinic acid, cadabicine, glucosilinate, ceryl alcohol, lupeol, and flavonoids. It is used in dysuria, amoebic dysentery, renal diseases, and swollen gums. Its pharmacological activities are lubricant, diuretic, and lithotriptic. Urolithic property of Crataeva nurvala has been reported. 7 Asparagus racemosus (Liliaceae). Parts used are leaves. 12 reported that Nigella sativa is useful in urolithiasis. This article gives comprehensive review on medicinal plants used to treat urolithiasis. These data could be used to highlight medicinal plants that could be studied more rigorously, and their clinical trials should be conducted. After clinical trials, these plants can be basis to recommended current clinical use.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
ORCID iD
Muhammad Idrees
https://orcid.org/0000-0001-8526 -8820
